| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |